A high throughput assay for identification of hepatitis C virus NS3 serine protease inhibitors.

被引：0
|
作者：
Zemel, R
Berdichevsky, Y
Bachmatove, L
Kunin, M
Golan-Goldhirsh, A
Tur-Kaspa, R
Benhar, I
机构：
[1] Tel Aviv Univ, Felsenstein Med Res Ctr, Petah Tiqwa, Israel
[2] Rabin Med Ctr, Petah Tiqwa, Israel
[3] Ben Gurion Univ Negev, Beer Sheva, Israel
[4] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1003
引用
收藏
页码：423A / 423A
页数：1
相关论文
共 50 条
  • [21] Hepatitis C virus NS3 serine protease inhibitors:: Discovery of potent P2′ moiety
    Arasappan, A
    Njoroge, FG
    Chan, TY
    Bennett, F
    Bogen, SL
    Chen, K
    Gu, H
    Hong, L
    Jao, E
    Liu, YT
    Lovey, RG
    Parekh, T
    Pike, RE
    Pinto, P
    Santhanam, B
    Venkatraman, S
    Vaccaro, H
    Wang, H
    Yang, X
    Zhu, Z
    Patel, N
    McCormick, J
    McKittrick, B
    Saksena, AK
    Girijavallabhan, V
    Pichardo, J
    Butkiewicz, N
    Ingram, R
    Malcolm, B
    Prongay, A
    Yao, N
    Marten, B
    Madison, V
    Kemp, S
    Levy, O
    Lim-Wilby, M
    Tamura, S
    Ganguly, AK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2603 - U2603
  • [22] Second-Generation Highly Potent and Selective Inhibitors of the Hepatitis C Virus NS3 Serine Protease
    Chen, Kevin X.
    Nair, Latha
    Vibulbhan, Bancha
    Yang, Weiying
    Arasappan, Ashok
    Bogen, Stephane L.
    Venkatraman, Srikanth
    Bennett, Frank
    Pan, Weidong
    Blackman, Melissa L.
    Padilla, Angela I.
    Prongay, Andrew
    Cheng, Kuo-Chi
    Tong, Xiao
    Shih, Neng-Yang
    Njoroge, F. George
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (05) : 1370 - 1379
  • [23] From tripeptide to capped dipeptide α-ketoacid inhibitors of Hepatitis C virus NS3 serine protease.
    Colarusso, S
    Gerlach, B
    Giuliano, C
    Koch, U
    Matassa, VG
    Narjes, F
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U658 - U658
  • [24] Evolution, synthesis and SAR of tripeptide α-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease
    Colarusso, S
    Gerlach, B
    Koch, U
    Muraglia, E
    Conte, I
    Stansfield, I
    Matassa, VG
    Narjes, F
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 705 - 708
  • [25] P2 diamino acid derivatives as hepatitis C virus NS3 serine protease inhibitors
    Arasappan, Ashok
    Njoroge, F. George
    Gu, Haining
    Parekh, Tejal N.
    Pichardo, John
    Butkiewicz, Nancy
    Prongay, Andrew
    Yao, Nanhua
    Girijavallabhan, Viyyoor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2604 - U2604
  • [26] NS3 serine protease inhibitors as potential antiviral agents for the treatment of hepatitis C virus infection.
    Llinàs-Brunet, M
    Bailey, M
    Cameron, D
    Ferland, JM
    Ghiro, E
    Gorys, V
    Goudreau, N
    Halmos, T
    Narl, H
    Poirier, M
    Rancourt, J
    Tsantrizos, Y
    Lamarre, D
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A73 - A73
  • [27] Key Binding and Susceptibility of NS3/4A Serine Protease Inhibitors against Hepatitis C Virus
    Meeprasert, Arthitaya
    Hannongbua, Supot
    Rungrotmongkol, Thanyada
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (04) : 1208 - 1217
  • [28] Hepatitis C virus NS3 serine protease interacts with the serpin Cl inhibitor
    Drouet, C
    Bouillet, L
    Csopaki, F
    Colomb, MG
    FEBS LETTERS, 1999, 458 (03) : 415 - 418
  • [29] Genetic screen for monitoring hepatitis C virus NS3 serine protease activity
    Martinez, MA
    Clotet, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) : 1760 - 1765
  • [30] ASUNAPREVIR HCV Serine Protease NS3 Inhibitor Treatment of Hepatitis C Virus
    Reviriego, C.
    DRUGS OF THE FUTURE, 2012, 37 (04) : 247 - 254
12345